A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects

A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects

A decrease in nicotinamide adenine dinucleotide (NAD+) levels is a hallmark of aging in multiple species, including humans. Our previous clinical trial showed that supplementation of 200 mg nicotinamide, a form of vitamin B3, increased blood NAD+ levels. Here we report a clinical trial to assess the...

Full description

Bibliographic Details
Main Authors: Takashi K. Ito, Tomohito Sato, Yusuke Takanashi, Zinat Tamannaa, Takuya Kitamoto, Keiichi Odagiri, Mitsutoshi Setou
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-01-01
Series:Translational Medicine of Aging
Subjects:
Clinical trial
Nicotinamide
NAD+
Lipidome
Online Access:http://www.sciencedirect.com/science/article/pii/S2468501121000055

Internet

http://www.sciencedirect.com/science/article/pii/S2468501121000055

Similar Items